Akgün et al. from Turkey investigated the efficacy and safety of non–vitamin K antagonist oral anticoagulants (NOACs) and warfarin in Turkish octogenarians with non-valvular atrial fibrillation in a real-world tertiary center setting. The results will encourage physicians to use NOACs in this elderly group.
展开▼